Chronic myelomonocytic leukaemia (Q39195): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Neoplasia mielodisplásica / mieloproliferativa caracterizada por monocitose persistente, ausência de cromossoma Philadelphia e gene de fusão BCR/ABL1, contagem de blastos menor do que 20% na medula óssea e no sangue, frequentemente mielodisplasia e ausência de rearranjo do PDGFRA (platelet-derived growth factor receptor alfa - receptor do fator de crescimento plaquetário alfa) ou PDGFRB (platelet-derived growth factor receptor beta - receptor do fator de crescimento plaquetário beta). | |||||||||||||||
| description / en | description / en | ||||||||||||||
A myelodysplastic/myeloproliferative neoplasm which is characterised by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL1 fusion gene, fewer than 20 percent blasts in the bone marrow and blood, often myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/2073226578 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:2A40 | |||||||||||||||
| Property / CURIE: CID11:2A40 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-2A40 | |||||||||||||||
| Property / Canary Token: dki-india-2A40 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: C93.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 04:32, 13 August 2026
A myelodysplastic/myeloproliferative neoplasm which is characterised by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL1 fusion gene, fewer than 20 percent blasts in the bone marrow and blood, often myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A40 |
||
| English | Chronic myelomonocytic leukaemia |
A myelodysplastic/myeloproliferative neoplasm which is characterised by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL1 fusion gene, fewer than 20 percent blasts in the bone marrow and blood, often myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement. |
Statements
CID11:2A40
0 references
dki-india-2A40
0 references
Concluído
0 references
13 August 2026
0 references
